3600-18-8

Basic information

• Product Name: AMIPROFOS METHYL
• Synonyms: Methyl 2-bromo-3-oxobutanoate;Butanoic acid, 2-broMo-3-oxo-, Methyl ester
• CAS NO: 3600-18-8
• Molecular Formula: C₅H₇BrO₃
• Molecular Weight: 195.01128
• Mol File: 3600-18-8.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 101.0-102.5 °C(Press: 17 Torr)
• Appearance: /
• Density: 1.5320 g/cm3
• PKA: 8.12±0.46(Predicted)
• CAS DataBase Reference: AMIPROFOS METHYL(CAS DataBase Reference)
• NIST Chemistry Reference: AMIPROFOS METHYL(3600-18-8)
• EPA Substance Registry System: AMIPROFOS METHYL(3600-18-8)

Safety Data

• Hazardous Substances Data: 3600-18-8(Hazardous Substances Data)

Usage

General Description

Amiprofos methyl is a pesticide and fungicide used to control a range of fungal and bacterial diseases in crops. It belongs to the organophosphate group of chemicals and works by inhibiting enzyme activity in the target organisms. AMIPROFOS METHYL is used in a variety of agricultural settings, including fruit and vegetable crops, ornamental plants, and turf. It is effective in controlling diseases such as anthracnose, downy mildew, and leaf spot, and is typically applied as a foliar spray to the plants. However, like all pesticides, it is important to use amiprofos methyl responsibly and follow safety guidelines to minimize the risk to human health and the environment.

Upstream product

• 105-45-3 acetoacetic acid methyl ester 
• 106775-99-9 methyl 2,2-dibromoacetoacetate 
• 34136-04-4 methyl acetoacetate 

Downstream Products

• 1175682-41-3 (1S,2R,3S)-methyl 1-acetyl-2-formyl-3-phenylcyclopropanecarboxylate 
• 1175682-45-7 (1S,2R,3S)-methyl 1-acetyl-2-formyl-3-(4-nitrophenyl)cyclopropanecarboxylate 
• 1175682-49-1 (1S,2R,3S)-methyl 1-acetyl-2-formyl-3-(4-bromophenyl)cyclopropanecarboxylate 
• 1175682-47-9 (1S,2R,3S)-methyl 1-acetyl-2-formyl-3-(4-cyanophenyl)cyclopropanecarboxylate 
• 4432-63-7 2-phenylacrolein 
• 939038-53-6 methyl 2-(1-(5-chloropyridin-2-yl)-1-(3-fluoro-5-(trifluoromethyl)phenyl)-2-phenylethylamino)-4-methylthiazole-5-carboxylate 
• 6289-46-9 dimethyl 2,5-dioxocyclohexane-1,4-dicarboxylate 
• 1415570-50-1 methyl 8-(((benzyloxy)carbonyl)amino)-2-methylimidazo[1,2-a]pyridine-3-carboxylate 
• 781654-81-7 methyl 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxylate 
• 943112-78-5 methyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate 
• 3829-80-9 2-amino-4-methylthiazole-5-carboxylic acid methyl ester 

Relevant articles and documents

Lipophilic indole mediated chemoselective α-monobromination of 1,3-dicarbonyl compounds

A mild and efficient mono-selective bromination of 1,3-dicarbonyl compounds has been developed using lipophilic indole catalysts. Inexpensive and commercially available N-bromosuccinimide (NBS) was used as the brominating reagent. The selectivity was further enhanced when using stoichiometric amount of 3-bromoindole species. Mechanistic studies reveal that the indole catalyst has dual functions in the mono-bromination process.

NBS mediated protocol for the synthesis of N-bridged fused heterocycles in water

A facile and environmental friendly protocol for the synthesis of N-bridged fused bicyclic compounds such as imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrimidines, and imidazo[2,1-b]thiazole, from commercially available starting materials has been developed.

Synthesis and antimicrobial activities of a series of 2,5-substituent 1,4-cyclohexanedione derivatives

A series of 2,5-substituent 1,4-cyclohexanedione derivatives compounds were designed and synthesized. Their structures were identified by elemental analysis, 1H NMR, IR spectra. Their assayed antibacterial (Escherichia coli, Bacillus subtilis) and antifungal (Candida albicans) activities were also evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method. The results of biological test showed 2,5-dibenzylformate 1,4-cyclohexanedione (11) and 2,5-diformanilide 1,4-cyclohexanedione (12) have favorable antimicrobial activity with MICs of 26.7, 33.6, 24.2 and 32.3 μg/mL against Escherichia coli and Bacillus subtilis, respectively. Copyright